A detailed history of Red Cedar Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Red Cedar Capital, LLC holds 2,652 shares of ABBV stock, worth $465,638. This represents 0.27% of its overall portfolio holdings.

Number of Shares
2,652
Previous 2,776 4.47%
Holding current value
$465,638
Previous $373,000 15.01%
% of portfolio
0.27%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $17,150 - $20,567
-124 Reduced 4.47%
2,652 $429,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $1,329 - $1,464
13 Added 0.47%
2,776 $300,000
Q1 2020

Apr 30, 2020

SELL
$64.5 - $97.79 $15,028 - $22,785
-233 Reduced 7.78%
2,763 $211,000
Q4 2017

Feb 12, 2018

BUY
$89.56 - $98.21 $268,321 - $294,237
2,996
2,996 $290,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Red Cedar Capital, LLC Portfolio

Follow Red Cedar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Cedar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Cedar Capital, LLC with notifications on news.